XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flow From Operating Activities:    
Net loss $ (385) $ (5,907)
Adjustments to reconcile net income (loss) applicable to common shares to net cash provided by (used in) operating activities:    
Gain on sale of land (1,335) (445)
Depreciation and amortization 6,391 6,330
Amortization of deferred borrowing costs 983 1,057
Amortization of bond issuance costs 299 141
Earnings from unconsolidated subsidiaries and investees (320) (55)
(Increase) decrease in assets:    
Accrued interest receivable 842 2,352
Other assets (1,468) (1,634)
Prepaid expense 7,365 (1,743)
Rent receivables 259 (1,521)
Related party receivables (7,621) 2,695
Increase (decrease) in liabilities:    
Accrued interest payable (2,796) 846
Other liabilities 1,291 (11,109)
Net cash provided by (used in) operating activities 3,505 (8,993)
Cash Flow From Investing Activities:    
Proceeds from notes receivables   2,352
Origination of notes receivables (11,118)  
Acquisition of land held for development (6,400)
Proceeds from sale of income producing properties 2,128
Proceeds from sale of land 3,649 1,089
Proceeds from insurance claim 413
Investment in unconsolidated real estate entities (54)
Improvement of land held for development (1,154)
Improvement of income producing properties (633) (1,063)
Assumption of non-controlling interest (67)
Construction and development of new properties (20,117) (8,469)
Net cash used in investing activities (26,091) (13,353)
Cash Flow From Financing Activities:    
Proceeds from bonds 39,399 75,991
Bond issuance costs (2,022) (4,829)
Proceeds from notes payable 17,343 47,577
Recurring amortization of principal on notes payable (7,415) (3,537)
Payments on maturing notes payable (16,750) (60,792)
Deferred financing costs (1,167)
Preferred stock dividends - Series A (225) (275)
Net cash provided by (used in) financing activities 30,330 52,968
Net increase in cash and cash equivalents 7,744 30,622
Cash and cash equivalents, beginning of period 88,538 55,921
Cash and cash equivalents, end of period 96,282 86,543
Supplemental disclosures of cash flow information:    
Cash paid for interest 13,375 13,806
Schedule of noncash investing and financing activities:    
Notes receivable received from sale of income-producing properties $ 6,384